Efficacy of Mesalazine in Children With Moderate to Severe Alopecia Areata: Case Series of 18 Patients

    Analú Vivian, Vânia Oliveira Carvalho, Ana Elisa Kiszewski
    Studysummary In this study of 18 children with moderate to severe alopecia areata in Brazil, mesalazine treatment showed varied responses, with 14 patients completing evaluations and two not responding after six months, amidst treatment challenges like relocation and the COVID-19 pandemic.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on sciencedirect.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Treatment of Alopecia Areata in Pre-Adolescent Children with Oral Tofacitinib: A Retrospective Study Pediatric Dermatology · 2020
    2. Consensus on the Treatment of Alopecia Areata – Brazilian Society of Dermatology Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia · 2020
    3. Mesalazine in the Treatment of Extensive Alopecia Areata: A New Therapeutic Option? International Journal of Trichology · 2018

    Related research 1

    1. Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child International journal of research in dermatology · 2019